These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Dysplastic platelets and circulating megakaryocytes in chronic myeloproliferative diseases. I. The platelets: ultrastructure and peroxidase reaction. Maldonado JE, Pintado T, Pierre RV. Blood; 1974 Jun; 43(6):797-809. PubMed ID: 4524752 [No Abstract] [Full Text] [Related]
9. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders. Brodsky I, Kahn SB, Ross EM, Petkov G. Cancer; 1972 Dec; 30(6):1444-50. PubMed ID: 4509103 [No Abstract] [Full Text] [Related]
10. Platelet function and arachidonate metabolism in patients with myeloproliferative disorders. Okuma M. Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1139-44. PubMed ID: 6800179 [No Abstract] [Full Text] [Related]
14. Platelet defects in the myeloproliferative disorders. Inceman S, Tangün Y. Ann N Y Acad Sci; 1972 Oct 27; 201():251-61. PubMed ID: 4509685 [No Abstract] [Full Text] [Related]
15. Blood histamine in the differential diagnosis of myeloid splenomegaly (osteomyelofibrosis) and other myeloproliferative disorders. Gingold N. Rev Roum Med; 1974 Oct 27; 12(1):15-8. PubMed ID: 4533361 [No Abstract] [Full Text] [Related]
16. Platelet function in patients with high platelet counts. Ginsburg AD. Ann Intern Med; 1975 Apr 27; 82(4):506-11. PubMed ID: 1054537 [Abstract] [Full Text] [Related]
17. Serum beta-2-microglobulin in disorders of myeloid proliferation. Norfolk DR, Child JA, Roberts BE, Forbes MA, Cooper EH. Acta Haematol; 1983 Apr 27; 69(6):361-8. PubMed ID: 6190339 [Abstract] [Full Text] [Related]